Although previously studied in patients with chronic kidney disease, there is less data for the use of cystatin C and cystatin C-based formulas in heart transplant recipients. The ability of creatinine and cystatin C to detect renal failure (glomerular filtration rate [GFR] below 60 mL/min/1.73 m 2 ) in heart transplant patients has been compared. The accuracy and precision of a creatinine-based formula (Modification of Diet in Renal Disease [MDRD]) versus a cystatin C-based formula (Rule's formula) to estimate GFR have also been studied. GFR was measured using the 51 Crethylenediamine tetraacetic acid tracer in 27 patients. There was no significant difference between GFR and the reciprocal of creatinine or cystatin C. Receiver operating characteristic curves for cystatin C and creatinine were similar. Both formulas were well correlated with the GFR. The bias of the cystatin C-based was significantly better than one of the MDRD formula, but the standard deviation appeared better for the MDRD formula (bias of ϩ3.9 mL/min/1.73 m 2 versus ϩ12 mL/min/1.73 m 2 and SD of 8.5 versus 11.6, respectively). Plasma cystatin C has no clear advantage over serum creatinine to detect renal failure in heart transplanted patients.
C
hronic renal failure is a common complication in heart transplant patients (1) (2) (3) . Serum creatinine is the classical marker used to detect renal failure. However, this marker has clear limitations because of serum concentration variations according to muscle mass and tubular secretion (3) (4) (5) . Plasma cystatin C is presented as a new marker of glomerular filtration rate (GFR) (6, 7) . Notably, its plasma concentration has been shown to be independent of the muscular mass (8) . Even if it remains controversial, several authors have described the superiority of plasma cystatin C over serum creatinine to detect renal failure (9 -11) . The goal of this study was to compare the interest of creatinine and cystatin C to detect renal failure in a population of heart transplant patients. Moreover, we have recently shown in the same cohort of patients that the Modification of Diet in Renal Disease (MDRD) formula was the best of the creatininebased formulae to estimate GFR (12) . Here, the MDRD formula was compared with a new cystatin C-based formula for the estimation of GFR (13) .
The study population consisted of 27 white patients. The exclusion criteria were age Ͻ15 years and a body mass index Ͼ35 kg/m 2 . The reference method for GFR measurement was based on plasma clearance of 51 Cr-ethylenediamine tetraacetic acid (EDTA) (14) . Results were corrected by body surface area (15) . Serum creatinine was measured with the kinetic rate-blanked compensated creatinine Jaffé method on Modular (Roche Diagnostics; reference values: Ͻ1.21 mg/dL for the men and Ͻ1.02 mg/dL for the women) (16) . Plasma cystatin C was measured by a particle-enhanced nephelometric immunoassay (Dade Behring) (17) . A value of cystatin C Ͻ1 mg/L may be considered as normal in the general population (18) .
The abbreviated MDRD formula used was: . A coefficient of correlation between the estimated GFR (by creatinine or cystatin-based formula) and the measured GFR was calculated. A Bland and Altman analysis was performed. The bias was defined as the mean of the differences between the predicted and measured GFR. The standard deviations of the mean differences between measured and estimated GFR reflect the precision of the estimation. Formulae accuracy was determined by the percentage of the estimated GFR within 30% of the measured GFR. Statistical analyses were performed using MedCalc (MedCalc Software, Mariakerke, Belgium).
GFR measurement was performed in 27 white heart transplant patients (five women, 22 men). The clinical characteristics of the population were described previously (12) . All patients had normal thyroid function. Among these 27 patients, 24 (89%) had a GFR lower than 60 mL/min/1.73 m 2 . After this first determination, the GFR was measured again at least 10 months later in 22 patients. The mean GFR 10 months later remained stable for those 22 patients. All isotopic GFR measurements (49) were pooled and their mean value was 39Ϯ15 mL/min/1.73 m 2 . A significant correlation between the GFR and the reciprocal of creatinine and cystatin C (rϭ0.75, PϽ0.0001 and rϭ0.66, PϽ0.0001, respectively) was found. There was no difference between these correlations (Fig. 1) .
To detect a GFR less than 60 mL/min/1.73 m 2 , the area under the curve was 0.86 for the creatinine and 0.83 for the cystatin C. The difference was not significant (Fig. 2) . The creatinine value that gave the best sensitivity-specificity was 1.32 mg/dL (sensitivity of 72.7%, specificity of 100%). For the cystatin C, the value was 1.51 mg/L (sensitivity of 81.1%, specificity of 83.3%).
Both MDRD and Rule formulae were moderately correlated with GFR (rϭ0.83 and rϭ0.66, respectively, no statistical difference). The coefficients of determinations (r 2 ) were also relatively low (0.69 and 0.44, respectively). The Bland and Altman analyses are given in Figure 3 . The precision of the MDRD formula is linked to the SD of the mean difference. The precision of the MDRD formula was statistically better than the Rule formula (SD 8.5 versus 11.6, Pϭ0.033). Nevertheless, the bias of the Rule cystatin-based formula was smaller than in the MDRD formula (ϩ3.9 mL/min versus ϩ12 mL/min, respectively, Pϭ0.0002). The GFR estimated with the MDRD formula was found within 30% measured GFR in 43% cases, whereas the percentages were 67% for the GFR estimated by the cystatin-based formula (Pϭ0.029).
Given the high prevalence of C-reactive protein, the detection of reduced GFR is of great importance in the heart transplant population (2, 3) . In this study, plasma cystatin C had no clear advantage over serum creatinine to detect renal failure. Nevertheless, for the estimation of GFR, the cystatin C-based equation could have some advantages over the MDRD equation.
Serum creatinine has a poor sensitivity to detect renal failure in the general population (5, 19) . This marker may be even less accurate in heart transplant recipients because this population has a reduced muscular mass, notably because of chronic therapy by corticosteroids (4, 20, 21) . Regarding transplant populations, Tomlanovich et al. have also shown some degree of creatinine tubular hypersecretion, dependent on cyclosporine therapy (4) . If the reference values of creatinine with our Jaffé method are considered, 63.6% of our patients with normal creatinine values had a GFR less than 60 mL/min/1.73 m 2 . Nevertheless, the specificity of the serum creatinine was excellent.
The ability for plasma cystatin C to detect renal failure was not better than for serum creatinine. This can be explained by the lack of specificity of the cystatin C. All patients, even those with a GFR greater than 60 mL/min/1.73 m 2 had high cystatin C levels. Two arguments are proposed to explain these results. Firstly, some factors can interfere with cystatin C concentrations (dysthyroidism, smoking, weight) (22, 23) . Maybe more important in the context of transplantation, some authors have suggested that corticoids can induce an increase of cystatin C concentration independently of any GFR changes (24, 25) . This fact is still debated (26) . However, in our patients, the cystatin C value that gives the best sensitivity-specificity rate was 1.51 mg/dL, which is higher than the maximal normal value obtained in a normal population (18) . The second explanation that may explain the lack of superiority of cystatin C may be linked to the range of GFR in our population. The majority of our patients had a GFR less than 60 mL/min/1.73 m 2 , although cystatin C is thought to be superior especially to detect a GFR between 60 and 80 mL/ min/1.73 m 2 (11, 27) . For the estimation of GFR, the Kidney/Disease Outcomes Quality Initiative (K/DOQI) guidelines recommend the use of creatinine-based formula and, among these, favor to the MDRD formula (19) . However, we have recently shown that MDRD precision and accuracy are less in heart transplanted patients than in other populations (12) . Recently, Rule et al. have elaborated a new cystatin-based formula from a large transplanted population. With the formula of Rule et al., the bias and the accuracy of the cystatin Cformula were significantly better than those of the MDRD. However, the precision reflected by the standard deviation and the correlation with GFR of the Rule formula was poor. Why this lack of precision? First, as we have already shown, cystatin C concentrations may be influenced by corticoids therapy. Our population was not homogeneous in term of corticotherapy, as 27% of our patients were corticoid-free. Moreover, the percentage of patients not treated by corticoids in the Rule study was not given. Secondly, the lack of precision of the cystatin C-based equations may be linked to the different assays for the cystatin C measurement and varied calibrations. Indeed, as it is the case with the creatinine, lack of precision or lack of calibration in the measurement of cystatin C will have great repercussions on the precision of cystatin C-based formulae (27) (28) (29) . As for creatinine (30) , harmonization and better precision are thus needed for the measurement of plasma cystatin C.
There are limitations to our study. Our sample was rather small. However, as we have already shown (12) , the GFR range of our population appeared quite representative of the GFR range in the global heart transplanted population. Of importance, the conclusions of our study remained similar when statistics were limited to the first 27 patients and to the 22 patients who had had two GFR measurements (data not shown).
Plasma cystatin C was not better than serum creatinine for detecting renal failure in a representative population of heart transplant patients. Nevertheless, if the serum creatinine of a heart transplant patient was abnormally high, one can conclude that this patient had a GFR less than 60 mL/ min/1.73 m 2 . In fact, with our creatinine assay, a value more than 1.32 mg/dL had a specificity of 100% to detect renal failure (and a sensitivity of 72.7%). With our cystatin C assay, a value more than 1.01 mg/L had a sensitivity of 100% but a very low specificity. In other words, if the plasma cystatin C was in the normal range, then the patient had a GFR of at least 60 mL/min/1.73 m 2 . The bias and the accuracy (but not the precision) of the cystatin C-based formula were better than those of the MDRD formula. These preliminary data have to be confirmed on a larger sample. If a precise GFR is needed in clinical practice or studies with heart transplant patients, we do recommend the use of a reference method measurement. 
